Cargando…

Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions

BACKGROUND: CSF-soluble platelet-derived growth factor receptor beta (sPDGFRβ) is closely associated with pericyte damage. However, the changes in CSF sPDGFRβ levels and their role in blood–brain barrier (BBB) leakage at different stages of Alzheimer’s disease (AD), with or without cerebral small ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Xinyi, Zhang, Mengguo, Cheng, Zhaozhao, Wang, Qiong, Wang, Peng, Xie, Qiang, Ni, Ming, Shen, Yong, Tang, Qiqiang, Gao, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012584/
https://www.ncbi.nlm.nih.gov/pubmed/36915135
http://dx.doi.org/10.1186/s13195-023-01199-5
_version_ 1784906632615952384
author Lv, Xinyi
Zhang, Mengguo
Cheng, Zhaozhao
Wang, Qiong
Wang, Peng
Xie, Qiang
Ni, Ming
Shen, Yong
Tang, Qiqiang
Gao, Feng
author_facet Lv, Xinyi
Zhang, Mengguo
Cheng, Zhaozhao
Wang, Qiong
Wang, Peng
Xie, Qiang
Ni, Ming
Shen, Yong
Tang, Qiqiang
Gao, Feng
author_sort Lv, Xinyi
collection PubMed
description BACKGROUND: CSF-soluble platelet-derived growth factor receptor beta (sPDGFRβ) is closely associated with pericyte damage. However, the changes in CSF sPDGFRβ levels and their role in blood–brain barrier (BBB) leakage at different stages of Alzheimer’s disease (AD), with or without cerebral small vessel disease (CSVD) burden, remain unclear. METHODS: A total of 158 individuals from the China Aging and Neurodegenerative Disorder Initiative cohort were selected, including 27, 48, and 83 individuals with a clinical dementia rating (CDR) score of 0, 0.5, and 1–2, respectively. CSF total tau, phosphorylated tau181 (p-tau181), Aβ40, and Aβ42 were measured using the Simoa assay. Albumin and CSF sPDGFRβ were measured by commercial assay kits. CSVD burden was assessed by magnetic resonance imaging. RESULTS: CSF sPDGFRβ was the highest level in the CDR 0.5 group. CSF sPDGFRβ was significantly correlated with the CSF/serum albumin ratio (Q-alb) in the CDR 0–0.5 group (β = 0.314, p = 0.008) but not in the CDR 1–2 group (β = − 0.117, p = 0.317). In the CDR 0–0.5 group, CSF sPDGFRβ exhibited a significant mediating effect between Aβ42/Aβ40 levels and Q-alb (p = 0.038). Q-alb, rather than CSF sPDGFRβ, showed a significant difference between individuals with or without CSVD burden. Furthermore, in the CDR 0.5 group, CSF sPDGFRβ was higher in subjects with progressive mild cognitive impairment than in those with stable mild cognitive impairment subjects (p < 0.001). Meanwhile, CSF sPDGFRβ was significantly associated with yearly changes in MMSE scores in the CDR 0.5 group (β = − 0.400, p = 0.020) and CDR 0.5 (A+) subgroup (β = − 0.542, p = 0.019). CONCLUSIONS: We provide evidence that increased CSF sPDGFRβ is associated with BBB leakage in the early cognitive impairment stage of AD, which may contribute to cognitive impairment in AD progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01199-5.
format Online
Article
Text
id pubmed-10012584
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100125842023-03-15 Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions Lv, Xinyi Zhang, Mengguo Cheng, Zhaozhao Wang, Qiong Wang, Peng Xie, Qiang Ni, Ming Shen, Yong Tang, Qiqiang Gao, Feng Alzheimers Res Ther Research BACKGROUND: CSF-soluble platelet-derived growth factor receptor beta (sPDGFRβ) is closely associated with pericyte damage. However, the changes in CSF sPDGFRβ levels and their role in blood–brain barrier (BBB) leakage at different stages of Alzheimer’s disease (AD), with or without cerebral small vessel disease (CSVD) burden, remain unclear. METHODS: A total of 158 individuals from the China Aging and Neurodegenerative Disorder Initiative cohort were selected, including 27, 48, and 83 individuals with a clinical dementia rating (CDR) score of 0, 0.5, and 1–2, respectively. CSF total tau, phosphorylated tau181 (p-tau181), Aβ40, and Aβ42 were measured using the Simoa assay. Albumin and CSF sPDGFRβ were measured by commercial assay kits. CSVD burden was assessed by magnetic resonance imaging. RESULTS: CSF sPDGFRβ was the highest level in the CDR 0.5 group. CSF sPDGFRβ was significantly correlated with the CSF/serum albumin ratio (Q-alb) in the CDR 0–0.5 group (β = 0.314, p = 0.008) but not in the CDR 1–2 group (β = − 0.117, p = 0.317). In the CDR 0–0.5 group, CSF sPDGFRβ exhibited a significant mediating effect between Aβ42/Aβ40 levels and Q-alb (p = 0.038). Q-alb, rather than CSF sPDGFRβ, showed a significant difference between individuals with or without CSVD burden. Furthermore, in the CDR 0.5 group, CSF sPDGFRβ was higher in subjects with progressive mild cognitive impairment than in those with stable mild cognitive impairment subjects (p < 0.001). Meanwhile, CSF sPDGFRβ was significantly associated with yearly changes in MMSE scores in the CDR 0.5 group (β = − 0.400, p = 0.020) and CDR 0.5 (A+) subgroup (β = − 0.542, p = 0.019). CONCLUSIONS: We provide evidence that increased CSF sPDGFRβ is associated with BBB leakage in the early cognitive impairment stage of AD, which may contribute to cognitive impairment in AD progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-023-01199-5. BioMed Central 2023-03-14 /pmc/articles/PMC10012584/ /pubmed/36915135 http://dx.doi.org/10.1186/s13195-023-01199-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lv, Xinyi
Zhang, Mengguo
Cheng, Zhaozhao
Wang, Qiong
Wang, Peng
Xie, Qiang
Ni, Ming
Shen, Yong
Tang, Qiqiang
Gao, Feng
Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions
title Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions
title_full Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions
title_fullStr Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions
title_full_unstemmed Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions
title_short Changes in CSF sPDGFRβ level and their association with blood–brain barrier breakdown in Alzheimer’s disease with or without small cerebrovascular lesions
title_sort changes in csf spdgfrβ level and their association with blood–brain barrier breakdown in alzheimer’s disease with or without small cerebrovascular lesions
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012584/
https://www.ncbi.nlm.nih.gov/pubmed/36915135
http://dx.doi.org/10.1186/s13195-023-01199-5
work_keys_str_mv AT lvxinyi changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions
AT zhangmengguo changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions
AT chengzhaozhao changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions
AT wangqiong changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions
AT wangpeng changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions
AT xieqiang changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions
AT niming changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions
AT shenyong changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions
AT tangqiqiang changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions
AT gaofeng changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions
AT changesincsfspdgfrblevelandtheirassociationwithbloodbrainbarrierbreakdowninalzheimersdiseasewithorwithoutsmallcerebrovascularlesions